Article

Addition of nitrous oxide anesthesia: stress reduction during cataract surgery

Author(s):

Investigators conducted a retrospective consecutive study in which they compared the outcomes using this approach with the results achieved with local anesthesia alone during cataract surgery.

Addition of nitrous oxide anesthesia: stress reduction during cataract surgery

Nitrous oxide may help to suppress intraoperative anxiety and memory and decrease and stabilize vital signs.

Japanese physicians reported that the use of a low concentration of nitrous oxide anesthesia during cataract surgery, along with local anesthesia, did not result in respiratory depression, abnormal vital signs, or nausea. This application may be useful to suppress intraoperative anxiety and memory and decrease and stabilize vital signs, according to first author Santaro Noguchi, MD, from the Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.

Patients were included who underwent bilateral cataract surgeries. The investigators reviewed the cases of 37 patients for whom room air inhalation (air group) was used and the cases of 45 patients for whom 30% low-concentration nitrous oxide anesthesia (70% oxygen, total 6 L/min) at the start of surgery (nitrous oxide group) was used.

The investigators monitored the systolic and diastolic blood pressure levels and heart rates at the beginning and end of surgery and the mean oxygen saturation (% SpO2) intraoperatively. The patients completed a questionnaire immediately postoperatively regarding the intraoperative pain, anxiety, memory, and nausea measured using the Visual Analogue Scale.

Nitrous oxide effects

The investigators reported that no patients had systemic symptoms or ocular complications that required treatment.

All of the changes observed between the nitrous oxide and air groups reached significance. The respective changes in the blood pressures were −5.38 ± 11.07 and 1.27 ± 13.61 mmHg (p=0.01); the changes in heart rates were −2.24 ± 6.76 and 0.89 ± 5.18 beats/minute (p=0.001); the intraoperative SpO2 levels were 99.05% ± 0.74% and 97.44% ± 1.31% (p<0.001); the intraoperative anxiety levels were 21.76 ± 23.2 and 37.17 ± 32.79 (p=0.002); and the intraoperative memory values were 55.24 ± 36.8 and 68.91 ± 33.81 (p=0.01). No nausea was experienced intraoperatively by any patients. No significant differences were seen in the diastolic blood pressures and degrees of intraoperative pain.

Based on these results, the authors concluded, “Low-concentration [nitrous oxide] anesthesia may not cause respiratory depression, abnormal vital signs, or nausea during cataract surgery. [Nitrous oxide] can suppress intraoperative anxiety and memory and decrease and stabilize vital signs.”

Reference
  1. Noguchi S, Nakakura S, Noguchi A, et al. Examination of the safety and effectiveness of low-concentration nitrous oxide anesthesia in cataract surgery. J Cataract Refract Surg.July 15, 2021.doi: 10.1097/j.jcrs.0000000000000749
Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Dr. Amir Ghanipour discusses light adjustable lenses for cataracts at EyeCon 2024
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
© 2024 MJH Life Sciences

All rights reserved.